Cancer Q1 Unclaimed

John Wiley and Sons Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer is a journal indexed in SJR in Oncology and Cancer Research with an H index of 292. Journal with a Single blind Peer Review review system, and It has a price of 2500 €. The scope of the journal is focused on Cancer, Medicine, Oncology, Cancer statistics, Cancer Diagnosis. It has an SJR impact factor of 3,065 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


2500 €

Gold OA


Green OA

0 €

Non OA




SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)



Aims and Scope

Cancer Medicine Oncology Cancer statistics Cancer Diagnosis

Best articles

2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome

View more

A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte-colony-stimulating factor support in patients with hormone-refractory prostate carcinoma

View more

A Phase II study of irinotecan in patients with advanced renal cell carcinoma

View more

A pilot study of rituximab in patients with recurrent, classic Hodgkin disease

View more

Adenosquamous carcinoma of the pancreas

View more

Advance directives in the intensive care unit of a tertiary cancer center

View more

Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus

View more

Aspergillus sinusitis in cancer patients

View more

Author reply

View more

Breast cancer detection among young survivors of pediatric Hodgkin lymphoma with screening magnetic resonance imaging

View more

Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party

View more

Cancer-related fatigue and its impact on functioning

View more

Cell-mediated immunity to varicella zoster virus in children being treated for cancer

View more

Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data

View more

Clinical and radiologic predictors of invasive pulmonary aspergillosis in cancer patients

View more

Cognitive behavior therapy for people with cancer

View more

Combined antineoplastic and antiretroviral therapy for patients with hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients

View more

Comparative molecular analysis of loss of heterozygosity in adenocarcinoma in bile duct brushings and corresponding surgical pathology specimens

View more

Comparison of hybrid capture 2 with in situ hybridization for the detection of high-risk human papillomavirus in liquid-based cervical samples

View more

Comparison of psychosocial adaptation and sexual function of survivors of advanced hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD

View more

Coronary artery disease mortality in patients treated for hodgkin's disease

View more

Correlation of bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes

View more

Cyproterone acetate--mechanism of action and clinical effectiveness in prostate cancer treatment

View more

Detection, treatment, and outcome of isolated supraclavicular recurrence in 42 patients with invasive breast carcinoma

View more


No comments ... Be the first to comment!